<DOC>
	<DOCNO>NCT02961699</DOCNO>
	<brief_summary>This prospective , randomize , single-site , safety efficacy study subject chronic venous stasis ulcer . Patients fall two category : treatment arm ( 24 subject ) non-treatment control arm ( 12 subject ) . The treatment group undergo small liposuction procedure receive placement autologous cell therapy ( stromal vascular fraction SVF ) inject around rim venous stasis wound ( subcutaneously ) follow standard wound debridement , saturation collagen dress material standard over-dressing . Control ( non-treatment ) subject receive debridement dressing change per standard care without SVF .</brief_summary>
	<brief_title>Healing Chronic Venous Stasis Wounds With Autologous Cell Therapy</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Postphlebitic Syndrome</mesh_term>
	<mesh_term>Postthrombotic Syndrome</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<mesh_term>Wounds , Nonpenetrating</mesh_term>
	<criteria>Males females 18 year age older venous leg ulcer present least six month respond standard wound therapy least one month prior study treatment one wound size 1025centimeters square inpatient outpatient treatment chronic venous ulcer ability subject give appropriate consent appropriate representative available Age &lt; 18 year age Patients pregnant currently breast feed female subject childbearing potential , pregnancy test must perform negative result know within 7 day prior procedure Patient BMI less equal 18.5 insufficient amount subcutaneous tissue allow recovery 100ml lipoaspirate Patients poor glucose metabolic control ( HgbA1c &gt; 9 ) history local neoplasm history local neoplasm history local neoplasm site administration History systemic malignant neoplasm within last 5 year Patients require Negative Pressure Wound Therapy ( NPWT ) limb amputation target wound time screen Wounds unable stag classify . For example , full thickness tissue loss actual depth ulcer completely obscure slough and/or eschar wound bed Wounds evidence necrosis debridement Severe vascular disease pathogenesis ulcer ( ABI &lt; 0.6 ) Clinical sign critical colonization local infection Prolonged ( &gt; 6 month ) use steroids Patients active regimen chemotherapy Patients receive radiation proximity wound Patients document history liver disease ALT value &gt; 400 Allergy sodium citrate `` caine '' type local anesthetic Subject opinion Investigator designee , unable comply requirement study protocol unsuitable study reason . This include completion Patient Reported Outcome instrument . Subject currently participate another clinical trial yet complete primary endpoint . Subject part vulnerable population , judgement investigator , unable give Informed Consent reason incapacity , immaturity , adverse personal circumstance lack autonomy . This may include : Individuals mental disability , person nursing home , child , impoverished person , person emergency situation , homeless person , nomad , refugee , incapable give informed consent . Vulnerable population also may include member group hierarchical structure university student , subordinate hospital laboratory personnel , employee Sponsor , member arm force , person keep detention .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>